Clinical Trial Update: Assessing the Effects of CytoSorb Hemoperfusion on the Development on Immunoparalysis [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing CytoSorb hemoperfusion effects on immunoparalysis in sepsis; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Deficiency
• Sepsis

Drugs mentioned

• CytoSorb

Snippet

Sponsor: Radboud University Medical Center | Conditions: Sepsis, Immune Deficiency | Phase 3 | Status: COMPLETED